Exact Mass: 810.2371032000001

Exact Mass Matches: 810.2371032000001

Found 33 metabolites which its exact mass value is equals to given mass value 810.2371032000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Inositol nicotinate

2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl pyridine-3-carboxylate

C42H30N6O12 (810.192162)

C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AC - Nicotinic acid and derivatives C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98151 - Niacin-based Antilipidemic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Xylohexaose

(2S,3R,4S,5R)-2-[(3R,4R,5R,6S)-6-[(3R,4R,5R,6S)-6-[(3R,4R,5R,6S)-6-[(3R,4R,5R,6S)-4,5-dihydroxy-6-[(3R,4R,5R)-4,5,6-trihydroxyoxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxyoxane-3,4,5-triol

C30H50O25 (810.264105)

beta-Xyl(p)<(alpha-Ara(f)-(1->2)>3)>-(1->4)-beta-Xyl(p)3)>-(1->4)-Xyl(p)|beta-Xyl(p)[(alpha-Ara(f)-(1->2)][alpha-Ara(f)-(1->3)]-(1->4)-beta-Xyl(p)[alpha-Ara(f)-(1->3)]-(1->4)-Xyl(p)

C30H50O25 (810.264105)

alpha-L-Rhap-(1 -> 4)-beta-D-GlcpA-(1 -> 6)-[alpha-L-Araf-(1 -> 4)]-beta-D-Galp-(1 -> 6)-alphabeta-D-Galp

C30H50O25 (810.264105)

C44H42O15

C44H42O15 (810.2523582)

beta-D-Xylp-(1->4)-3)>-2)>-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp|beta-D-Xylp-(1->4)-[alpha-L-Araf-(1->2)-[alpha-L-Araf-(1->3)]]-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp|beta-D-Xylp-(1->4)-[alpha-L-Araf-(1->3)]-[alpha-L-Araf-(1->2)]-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp|beta-D-Xylp-(1->4)<(alpha-L-Araf-(1->2)>3)>-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp

beta-D-Xylp-(1->4)-3)>-2)>-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp|beta-D-Xylp-(1->4)-[alpha-L-Araf-(1->2)-[alpha-L-Araf-(1->3)]]-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp|beta-D-Xylp-(1->4)-[alpha-L-Araf-(1->3)]-[alpha-L-Araf-(1->2)]-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp|beta-D-Xylp-(1->4)<(alpha-L-Araf-(1->2)>3)>-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp

C30H50O25 (810.264105)

C40H42O18

C40H42O18 (810.2371032000001)

Koelzioside

C41H46O17 (810.2734866000001)

(1,3-O-di-p-coumaroyl-6-O-feruloyl)-beta-D-fructofuranosyl-(2->1)-alpha-D-glucopyranoside|smilaside G

C40H42O18 (810.2371032000001)

beta-Xyl(p)-(1->4)-beta-Xyl(p)3)>-(1->4)-beta-Xyl(p)3)>-(1->4)-Xyl(p)|beta-Xyl(p)-(1->4)-beta-Xyl(p)[alpha-Ara(f)-(1->3)]-(1->4)-beta-Xyl(p)[alpha-Ara(f)-(1->3)]-(1->4)-Xyl(p)

C30H50O25 (810.264105)

Inositol niacinate

inositol nicotinate

C42H30N6O12 (810.192162)

Liensinine diperchlorate

4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[[(1R)-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenol;perchloric acid

C37H44Cl2N2O14 (810.2169464000001)

Liensinine Diperchlor?ate is a major isoquinoline alkaloid, extracted from the seed embryo of Nelumbo nucifera Gaertn. Liensinine Diperchlor?ate inhibits late-stage autophagy/mitophagy through blocking autophagosome-lysosome fusion. Liensinine Diperchlor?ate has a wide range of biological activities, including anti-arrhythmias, anti-hypertension, anti-pulmonary fibrosis, relaxation on vascular smooth muscle, etc[1]. Liensinine Diperchlor?ate is a major isoquinoline alkaloid, extracted from the seed embryo of Nelumbo nucifera Gaertn. Liensinine Diperchlor?ate inhibits late-stage autophagy/mitophagy through blocking autophagosome-lysosome fusion. Liensinine Diperchlor?ate has a wide range of biological activities, including anti-arrhythmias, anti-hypertension, anti-pulmonary fibrosis, relaxation on vascular smooth muscle, etc[1].

C41H46O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2-O-Acetyl-6-deoxy-3,4-bis-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside

NCGC00384953-01_C41H46O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2-O-Acetyl-6-deoxy-3,4-bis-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside

C41H46O17 (810.2734866000001)

inositol nicotinate

Inositol hexanicotinate

C42H30N6O12 (810.192162)

CATECHIN PENTABENZOATE

C50H34O11 (810.2101014)

beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-Araf

C30H50O25 (810.264105)

5-(acetyloxy)-6-{[2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-2-methyl-4-[(3-phenylprop-2-enoyl)oxy]oxan-3-yl 3-phenylprop-2-enoate

5-(acetyloxy)-6-{[2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-2-methyl-4-[(3-phenylprop-2-enoyl)oxy]oxan-3-yl 3-phenylprop-2-enoate

C41H46O17 (810.2734866000001)

(2s,3r,4s,5s,6r)-2-{3-[(1e)-2-[(2r,3r)-3-(3,4-dihydroxyphenyl)-2-(3-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]ethenyl]-5-hydroxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{3-[(1e)-2-[(2r,3r)-3-(3,4-dihydroxyphenyl)-2-(3-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]ethenyl]-5-hydroxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C40H42O18 (810.2371032000001)

(2s,3r,4s,5s,6r)-2-{3-[(1e)-2-[(2r,3r)-2-(3,4-dihydroxyphenyl)-7-hydroxy-3-(3-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2,3-dihydro-1-benzofuran-5-yl]ethenyl]-5-hydroxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{3-[(1e)-2-[(2r,3r)-2-(3,4-dihydroxyphenyl)-7-hydroxy-3-(3-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2,3-dihydro-1-benzofuran-5-yl]ethenyl]-5-hydroxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C40H42O18 (810.2371032000001)

(3,4,5-trihydroxy-6-{[4-hydroxy-2-(hydroxymethyl)-3-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5-({[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)oxolan-2-yl]oxy}oxan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(3,4,5-trihydroxy-6-{[4-hydroxy-2-(hydroxymethyl)-3-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5-({[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)oxolan-2-yl]oxy}oxan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H42O18 (810.2371032000001)

5-(acetyloxy)-2-{[2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyl-4-{[(2e)-3-phenylprop-2-enoyl]oxy}oxan-3-yl (2e)-3-phenylprop-2-enoate

5-(acetyloxy)-2-{[2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyl-4-{[(2e)-3-phenylprop-2-enoyl]oxy}oxan-3-yl (2e)-3-phenylprop-2-enoate

C41H46O17 (810.2734866000001)

[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2s,3s,4r,5r)-4-hydroxy-2-(hydroxymethyl)-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)oxolan-2-yl]oxy}oxan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2s,3s,4r,5r)-4-hydroxy-2-(hydroxymethyl)-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)oxolan-2-yl]oxy}oxan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H42O18 (810.2371032000001)